Obsessive-Compulsive Disorder: Strategies to Maximize Opportunities in a Small Market
Topics: Research & Development, CNS/Neurology, Behavioral Health
|
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
|
Can a New Antidepressant Establish Itself in a Highly Competitive Market?
Topics: CNS/Neurology, Behavioral Health
|
The Antipsychotics Market Insight & Analysis 2008
Topics: CNS/Neurology, Behavioral Health
|
Plimsoll Portfolio Analysis - Mental Health Centres
Topics: Facilities, Behavioral Health
Regions: United Kingdom
|
Conference Documentation: Depression & Anxiety
Topics: Drug Discovery, Behavioral Health
|
The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System
Topics: Obesity, Pain, Alzheimer's Disease, Medical Devices, CNS/Neurology, Behavioral Health
|
Smoking Cessation and Addiction Treatments: A World Market Analysis
Topics: Wellness/Prevention Programs, Pharmaceuticals, Prescription Drugs, Respiratory/Pulmonary, Behavioral Health, Smoking Cessation
Regions: Global
|
Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market
Topics: CNS/Neurology, Behavioral Health
Regions: United States
|
Psychiatric & Other Specialist Hospital Services in Indonesia
Topics: Facilities, Behavioral Health
Regions: Indonesia
|
Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market
Topics: Research & Development, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: Global
|
Disease and Therapy Review: Bipolar Disorder
Topics: CNS/Neurology, Behavioral Health
Regions: Global
|
Atypical Antipsychotics: Life-Cycle Management and Future Trends
Topics: Pharmaceuticals, Prescription Drugs, CNS/Neurology, Behavioral Health
|
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD) Chapter
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Anti-addiction Therapies, 2006-2011 - The Pharmaceutical Industry’s Next Viagra?
Topics: Pharmaceuticals, Research & Development, CNS/Neurology, Behavioral Health, Smoking Cessation
|
The 2007-2012 Outlook for Psychotherapeutic Antidepressant Agents in the United States
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants in the United States
Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives in the United States
Topics: Prescription Drugs, Behavioral Health
|
The 2007-2012 Outlook for Antidepressant Pharmaceuticals in the United States
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States
|
Residential Mental Health and Substance Abuse Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
Conference Documentation: Depression & Anxiety
Topics: Prescription Drugs, Drug Discovery, Behavioral Health
|
European Antidepressants Markets
Topics: Behavioral Health
Regions: Europe
|
The 2007-2012 World Outlook for Psychotherapeutic Antidepressant Agents
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, Behavioral Health
Regions: Global
|
The 2007-2012 World Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Residential Mental Retardation Facilities in the US
Topics: Behavioral Health
Regions: United States
|
Antidepressants
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Sleeper Diseases: Forecast and Assessment of Neglected Disease Market Opportunities
Topics: Diseases & Conditions, Respiratory/Pulmonary, Behavioral Health
|
Impact of Generics on the Antidepressant Market
Topics: Pharmaceuticals, Generics Drugs, Prescription Drugs, Behavioral Health
|
Residential Mental Health and Substance Abuse Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactivity Disorder Market
Topics: CNS/Neurology, Behavioral Health
|
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012
Topics: Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States, Global
|
Residential Mental Retardation Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
The World Market for Antidepressants, 2006
Topics: Prescription Drugs, Behavioral Health
|
Emotional and Behavioral Disorders in Children and Adolescents
Topics: Children, Teens (13-19), Behavioral Health
|
Residential Mental Retardation Facilities in the US
Topics: General Facilities, Behavioral Health
Regions: United States
|
Opportunities in the Pharmacotherapy of Addiction
Topics: Behavioral Health
|
The 2006-2011 World Outlook for Psychotherapeutic Antidepressant Agents
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, Behavioral Health
Regions: Global
|
The 2006-2011 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
The 2006-2011 World Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
US Antidepressants 2004
Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
U.S. Antipsychotic Medications Markets
Topics: Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States
|
Antidepressants: World Prescription Drug Markets
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Stress Management
Topics: Behavioral Health
|
US Antidepressants 2003
Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The Expanding Market for Psychotherapeutic Drugs
Topics: Prescription Drugs, Behavioral Health
|
U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets
Topics: CNS/Neurology, Behavioral Health
Regions: United States
|
Marketlooks: Prescription Generic Central Nervous System and Psychotherapeutic Drugs
Topics: Generics Drugs, Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Substance Abuse Disorders: A focus on the smoking cessation and alcohol addiction markets
Topics: Prescription Drugs, Behavioral Health, Smoking Cessation
|
The World Market for Psychiatric Drugs
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
European Psychotropic Pharmaceutical Markets
Topics: Prescription Drugs, Behavioral Health
Regions: Europe
|
